SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today reported financial results for the fourth quarter and year ended December 31, 2025. “2025 was a year of strategic importance for Nkarta as we onboarded a clinical team with de...
SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today reported financial results for the fourth quarter and year ended December 31, 2025. “2025 was a year of strategic importance for Nkarta as we onboarded a clinical team with deep autoimmune experience, right-sized our workforce to be a responsible steward of investor capital, and continued to advance our CAR-NK cell therapy platform through dose escalation in the clinic,” said Paul J. Hastings, Chief Executive Officer of Nkarta. “Thoughtfully leveraging our safety data, we are now dosing patients at 4 billion cells in a three-dose cycle for a total of 12 billion cells as we look to maximize the depth and durability of B-cell depletion and clinical response, positioning us to unlock the full potential of NKX019 for people living with autoimmune disease.”
MINNEAPOLIS, March 25, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ended December 31, 2025, and other recent business developments.
MINNEAPOLIS, March 25, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the fourth quarter and full year ended December 31, 2025, and other recent business developments.
The following companies are expected to report earnings prior to market open on 03/26/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Commercial Metals Company (CMC)is reporting for the quarter ending February 28, 2026. The steel company's consens
The following companies are expected to report earnings prior to market open on 03/26/2026. Visit our Earnings Calendar for a full list of expected earnings releases.Commercial Metals Company (CMC)is reporting for the quarter ending February 28, 2026. The steel company's consens
Honda Motor Co. ’s costly misfire on electric cars has dramatically increased the stakes for the company to avoid making the same mistakes with motorcycles. Almost one out of every three motorcycles sold globally is a Honda, generating the majority of the manufacturer’s operating profit despite accounting for less than a fifth of sales. Even so, cracks are starting to appear as e-bikes from China ...
Honda Motor Co. ’s costly misfire on electric cars has dramatically increased the stakes for the company to avoid making the same mistakes with motorcycles. Almost one out of every three motorcycles sold globally is a Honda, generating the majority of the manufacturer’s operating profit despite accounting for less than a fifth of sales. Even so, cracks are starting to appear as e-bikes from China encroach on its turf. Though cars will undoubtedly be the focus of Chief Executive Officer Toshihiro Mibe ’s turnaround plan in May, he will also face pressure to show investors he won’t squander Honda’s best-performing unit. How the company adapts to an electric future will be central to whether it can stabilize earnings and restore investor confidence. “What’s happening with automobiles is the most likely scenario for two-wheelers,” said Hikaru Todoroki, principal auto consultant for KPMG. “Competition is intensifying.” Read More: Honda Could Get BYD-ed in Key Scooter Market: David Fickling A spokesperson for Honda declined to comment on electrification and motorcycles. Honda’s motorcycle business is already encountering growing competition. The manufacturer began its global electric motorcycle rollout three years ago with two models each in Indonesia and India, but the South Asian debut struggled. Of the two introduced in India, one relied on battery swapping without home charging, limiting usability, while the other paired fast charging with a significantly higher price than rivals. India, which accounts for roughly a third of the global motorcycle market, has drawn a wave of competitors racing to introduce new models, advance technology and secure battery supplies largely controlled by China and South Korea. Apart from Yadea Group Holdings Ltd. , the world’s largest electric bike maker by volume, newcomers such as VinFast Auto Ltd. in Vietnam, Gogoro Inc. in Taiwan and Bajaj Auto Ltd. in India are all seeking to expand their footprint. “Making an aggressive effort to a...
Ekaterina79/iStock via Getty Images The consensus remains bullish on inflationary expectations, including precious metals, stocks, and oil. But then, recency bias is the typical human response. It’s worth considering that cycle peaks could be behind us. Gold pared dramatic losses as US President Donald Trump postponed military strikes against Iranian energy infrastructure for a five-day period aft...
Ekaterina79/iStock via Getty Images The consensus remains bullish on inflationary expectations, including precious metals, stocks, and oil. But then, recency bias is the typical human response. It’s worth considering that cycle peaks could be behind us. Gold pared dramatic losses as US President Donald Trump postponed military strikes against Iranian energy infrastructure for a five-day period after what he described as productive talks toward ending hostilities. Oil also fell sharply, posting one of the biggest intraday price swings on record, after President Donald Trump postponed strikes on Iranian power plants and said his team held discussions about ending the conflict, though Tehran denied any such dialog. Bloomberg’s Mike McGlone joins to discuss on Bloomberg Intelligence. Here is a direct video link. As prices fall, leveraged participants necessitate selling across all assets to pay down margin debt (shown in red below since 1995, with the S&P 500 price in black). Longer-term support tests remain far below current levels (S&P 500 shown below since the end of 2019, courtesy of Bespoke). Food for thought when reviewing one’s risk management plans and assumptions. Most people have no idea that current stock valuation extremes mean prices can halve and remain within a secular uptrend. Disclosure: No positions Original Post Editor's Note: The summary bullets for this article were chosen by Seeking Alpha editors.
Jonathan Kitchen/DigitalVision via Getty Images Improving AI technology is proving a challenge to software companies, but Joseph Bonner, Senior Analyst with Argus Research, tells MoneyTalk some firms will still be able to thrive in this environment. Transcript Anthony Okolie: Software stocks have been under pressure this year as investors weigh the potential disruptive power of AI. But can some co...
Jonathan Kitchen/DigitalVision via Getty Images Improving AI technology is proving a challenge to software companies, but Joseph Bonner, Senior Analyst with Argus Research, tells MoneyTalk some firms will still be able to thrive in this environment. Transcript Anthony Okolie: Software stocks have been under pressure this year as investors weigh the potential disruptive power of AI. But can some companies in this space still thrive in this environment? Joining us now to discuss is Joe Bonner, senior analyst with Argus Research. Joe, welcome back to the show. Joseph Bonner: Good afternoon. Anthony Okolie: All right, Joe, we've seen a lot of volatility in the software stocks because, again, a concern about the potential for AI to disrupt their businesses, the so-called SaaS-pocalypse. What's your view? And has the worst passed for these stocks? Joseph Bonner: Yeah, well, to make a long story short, I think the worst has passed us. Whether you call it the SaaS-pocalypse or SaaS-mageddon, different words for the same thing. These companies, let's just take a couple of examples first, salesforce.com, Salesforce ( CRM ), and -- these companies are basically down 30%, 35% in the last year. They bounced back like 6% to 7% in the last month. So you can see some easing of that kind of unease. Just taking a step back for a minute, what actually happened? This unease in the market about AI replacing software-as-a-service companies has been around for a year or more. Last November, Google Gemini 3 came out. A new Claude update came out from Anthropic. Anthropic also had a new -- later on, new application, a co-work application. These new models were a significant improvement. And they were aimed at, basically, enterprise customers. So that basically crystallized this unease in the market that, somehow, the enterprise companies would decide, we're going to do it -- we're going to do it ourselves, basically, through AI rather than hiring a -- or licensing software from a SaaS compa...
The Global X Silver Miners ETF ( NYSEMKT: SIL ) and the iShares MSCI Global Silver and Metals Miners ETF ( NYSEMKT: SLVP ) both target global silver mining equities. But SLVP pays a higher dividend and has outperformed over one year, while SIL charges higher fees. Both SIL and SLVP are designed for investors seeking exposure to global silver miners, but they differ in scale, cost, and portfolio co...
The Global X Silver Miners ETF ( NYSEMKT: SIL ) and the iShares MSCI Global Silver and Metals Miners ETF ( NYSEMKT: SLVP ) both target global silver mining equities. But SLVP pays a higher dividend and has outperformed over one year, while SIL charges higher fees. Both SIL and SLVP are designed for investors seeking exposure to global silver miners, but they differ in scale, cost, and portfolio construction. This comparison breaks down their key differences in fees, performance, risk, sector exposure, and liquidity to help investors decide which may better fit their objectives. Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Continue reading
Micron stock sinks on debt reduction announcement and Google’s release of TurboQuant. But options traders seem to believe that MU shares are poised for a comeback.
Micron stock sinks on debt reduction announcement and Google’s release of TurboQuant. But options traders seem to believe that MU shares are poised for a comeback.
The Vanguard Value ETF (NYSEMKT:VTV) and the Vanguard Total Stock Market ETF (NYSEMKT:VTI) are both solid investments, but they approach the U.S. equity market differently. VTV targets large-cap value stocks , emphasizing established companies in sectors like financials and healthcare. VTI, on the other hand, captures nearly the entire U.S. stock market, spanning large-, mid-, and small-cap stocks...
The Vanguard Value ETF (NYSEMKT:VTV) and the Vanguard Total Stock Market ETF (NYSEMKT:VTI) are both solid investments, but they approach the U.S. equity market differently. VTV targets large-cap value stocks , emphasizing established companies in sectors like financials and healthcare. VTI, on the other hand, captures nearly the entire U.S. stock market, spanning large-, mid-, and small-cap stocks across all sectors. This comparison breaks down the key differences to help investors decide which approach may better align with their goals. Continue reading
A tearful Savannah Guthrie, in her first interview since her 84-year-old mother was apparently abducted from her Arizona home, said that “someone needs to do the right thing” and come forward with information to help the investigation. “We are in agony,” she told NBC News colleague Hoda Kotb in a portion of the interview broadcast on Wednesday on the Today show. She said she wakes up in the middle...
A tearful Savannah Guthrie, in her first interview since her 84-year-old mother was apparently abducted from her Arizona home, said that “someone needs to do the right thing” and come forward with information to help the investigation. “We are in agony,” she told NBC News colleague Hoda Kotb in a portion of the interview broadcast on Wednesday on the Today show. She said she wakes up in the middle of each night thinking of what her mother went through. NBC said on Wednesday that a full interview...
LilliDay/iStock via Getty Images The private credit markets are doing their utmost best to remind experienced investors of the subprime crisis that preceded the Great Financial Crisis. The contagion seems to be spreading. Private credit fund investors can be forgiven for playing this specific passage from the Hotel California by the Eagles in their heads over the past few weeks. This is as major p...
LilliDay/iStock via Getty Images The private credit markets are doing their utmost best to remind experienced investors of the subprime crisis that preceded the Great Financial Crisis. The contagion seems to be spreading. Private credit fund investors can be forgiven for playing this specific passage from the Hotel California by the Eagles in their heads over the past few weeks. This is as major private credit funds have put notable gates on redemption requests. Last thing I remember, I was running for the door. I had to find the passage back to the place I was before. "Relax," said the night man, "We are programmed to receive. You can check out any time you like, but you can never leave." ZeroHedge, Macro Bulter Every week the news feels like it is getting worse for private credit funds and their investors. These are just some of the headlines from CNBC this week on the increasing travails in this space. A $14 billion private credit fund run by KKR & Co. ( KKR ) and Future Standard was downgraded to Junk by Moody's. The ratings agency noted that non-accrual loans had amounted to 5.5% of Future Standard's loan book. One of the highest levels in the Business Development Company, or BDC, sector. The fund was also cited for a lower percentage of first-lien loans than its peers. Jeffrey Gundlach, A KA the ' Bond King,' noted on CNBC recently. Among the many points the famed billionaire bond investor made was that the current environment was reminding him in some ways of the lead-up to the Great Financial Crisis. Specifically, ' asset prices looked elevated, and initial signs of trouble in certain lending markets were downplayed as isolated incidents.' He also made several observations about the current private credit markets. Jeffrey Gundlach, CapWolf, CNBC ' Gating ' has entered the investor lexicon since private credit redemption problems first cropped up at Blue Owl Capital ( OWL ) in the second half of February. Lark Davis - March 2026 Since then, well-known names l...
Torsten Asmus/iStock via Getty Images The State Street SPDR Portfolio Int Term Corp Bd ETF ( SPIB ) is now under the spell of a new market factor, which is the oil crisis due to the Iran War, as opposed to tariff considerations last time we covered them . For a corporate bond ETF, there are two dimensions: credit spreads and the underlying benchmark rates. The oil crisis is inflationary and a macr...
Torsten Asmus/iStock via Getty Images The State Street SPDR Portfolio Int Term Corp Bd ETF ( SPIB ) is now under the spell of a new market factor, which is the oil crisis due to the Iran War, as opposed to tariff considerations last time we covered them . For a corporate bond ETF, there are two dimensions: credit spreads and the underlying benchmark rates. The oil crisis is inflationary and a macro threat, so YTMs are creeping up from both dimensions, which is bad for an intermediate-duration ETF like the SPIB at 4 years . The latest on the Iran War is that some ships are passing through. Risk takers are taking the trip through the Strait to benefit from the higher oil prices, and apparently Iran is to some extent willing to let ships through that are not associated with countries they feel are supporting the War, subject to quite considerable transit fees. It's still significantly better that there is some trade as opposed to none, and it is reflecting in the oil price and the oil futures curve as well. But the transit fees are still very considerable at around $2 million for the voyages they toll, where a 25-day voyage could be from the mid to high $100ks. There are a lot of pressures still on oil logistics, and the war in that region is continuing. The uncertainty also remains exceptionally high as to what can be believed or not, including whether negotiations have taken place or the extent of damage to Iran's military capabilities. Arguably, the latter isn't even relevant due to the asymmetry of the warfare, with low-cost drones needing interception from expensive missiles. While markets are absorbing the information that some oil is coming through, with considerable tolls and considerable risks, logistics supply is only transiting the Strait because the prices are so attractive, so we see there being quite a high floor. Consequently, reinflation risks, where underlying inflation was already a little hot before the war, remains a primary consideration for SPIB i...
Luis Alvarez/DigitalVision via Getty Images Withdrawal of Novo lawsuit against Hims removes a legal liability concern Hims’ 2026 rollercoaster ride started on February 5 th when it announced offering a much cheaper $49 compounded version of Novo Nordisk’s Wegovy weight-loss pill. The intention was to tap roughly 200 mln obese or overweight Americans. Hims' pricing was $49 for the first month and $...
Luis Alvarez/DigitalVision via Getty Images Withdrawal of Novo lawsuit against Hims removes a legal liability concern Hims’ 2026 rollercoaster ride started on February 5 th when it announced offering a much cheaper $49 compounded version of Novo Nordisk’s Wegovy weight-loss pill. The intention was to tap roughly 200 mln obese or overweight Americans. Hims' pricing was $49 for the first month and $99 afterwards for those who purchase a five-month plan. As a matter of fact, it was $100 less than Novo that launched its pill in January at $149 for first-time users and $199 for subsequent months. Hims cancelled the planned launch just after two days following severe legal threats from Novo and FDA backlash. Moreover, Novo sued Hims on February 9 th for patent infringement and pursued damages. Hims’ stock price plunged approx. 50% from almost $30 to a low of nearly $14.5 in end-February (Chart 1). Thereafter, a deal was struck between Novo and Hims on March 9 th . Under the deal, Novo dropped the patent violation lawsuit against Hims. As part of the arrangement, Hims will now offer Novo Nordisk medications i.e. Wegovy and Ozempic through its platform. At the same time, HIMS will be precluded to advertise compounded GLP-1s on its platform or marketing materials. Hims’ stock shot up 40% in the immediate aftermath and soared nearly 80% from its Feb-low. In our view, this resolution removes a serious legal drag on Hims’ stock and eliminates the risk of future compensatory damages. Chart 1 - Hims Share Price Chart Bloomberg Hims’ valuations have not fully recovered to the pre-litigation levels This was not the first time that Hims and Novo did not see eye to eye. In April 2025 , Novo Nordisk entered into an arrangement with Hims and others to sell Wegovy though their platforms. The agreement was short-lived with Novo sacking the deal in June 2025 . Novo stated that it had reservations over Hims' marketing tactics and continued sales of Wegovy copies. Even during this controver...